Regulatory approval of Vaxzevria (previously COVID-19 Vaccine AstraZeneca), MHRA (updated 19th October 2021)

Information for healthcare professionals and the public about Vaxzevria (previously COVID-19 Vaccine AstraZeneca). 19 October 2021Updated information for healthcare professionals and for patients 9 September 2021Updated sections of Information for Healthcare Professionals on COVID-19 Vaccine AstraZeneca (Regulation 174) and Information for UK recipients on COVID-19 Vaccine AstraZeneca (Regulation 174) to include information about receiving a third dose. Also updated the Regulation 174 Conditions document with additional pharmacovigilance conditions.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news